Mayne Pharma flags late evidence concerns in suit over $672M Cosette merger

Healthcare 2025-07-31 11:56 pm By Andy Sidler Melbourne

Please login to bookmark

Mayne Pharma has said it may seek to shut out US drug maker Cosette’s expert evidence in proceedings over the purported termination of their $672 million merger.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au